cis-3-(4-tert-Butoxycarbonylaminocyclohexyl)propionic acid, 95.0%, 250mg

5-BROMO-2H-BENZO[E][1,2,4]THIADIAZIN-3(4H)-ONE 1,1-DIOXIDE, 95.0%, 100mg

4-Methoxytriphenylamine, 99.00%, 1g

Ethyl-4-amino-3-chlorobenzoate, 97.0%, 250mg

2-Methyl-3-nitrophenylboronic acid, 95.0%, 10g

5-(chloromethyl)-1-(3-ethoxypropyl)-2-methanesulfonyl-1H-imidazole, 95.0%, 2g

9-Phenyl-9H-xanthen-9-ol, 97.0%, 5g

Ethyl 2-(2-oxo-1,3-oxazolidin-3-yl)acetate, 95%, 1g

6-Chloro-1H-indol-3-yl butyrate, 95.0%, 5mg

tert-butyl (2S,4R)-2-[4-(4-bromophenyl)-1H-imidazol-2-yl]-4-hydroxypyrrolidine-1-carboxylate, 95%, 100mg

2-(4-hydroxyphenyl)-2-(phenylamino)acetonitrile, 95.0%, 2g

CDTA, min. 99%, for synthesis, 250 g, plastic packaging.

1-(tert-Butyldimethylsilyl)-5-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole, 95.0%, 250mg